insights_auto
Why is NXTCL up 5.96%?
Dive Deeperchevron_right
NXTCL:STO
NextCell Pharma AB
SEK 0.24
arrow_upward
+5.96%(+0.013) 1D
Nov 17, 2:01:15 PM GMT+1 · SEK
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for NXTCL...
Open
SEK 0.24
High
SEK 0.25
Low
SEK 0.23
Mkt. cap
30.33M
Avg. vol.
1.00M
Volume
123.52K
52-wk high
SEK 1.78
52-wk low
SEK 0.20
EPS
-SEK 0.45
Shares outstanding
111.39M
No. of employees
21
Open
SEK 0.24
High
SEK 0.25
Low
SEK 0.23
Mkt. cap
30.33M
Avg. vol.
1.00M
Volume
123.52K
52-wk high
SEK 1.78
52-wk low
SEK 0.20
EPS
-SEK 0.45
Shares outstanding
111.39M
No. of employees
21
News stories
From web sources and news partners
Investor's Business Daily
·
20 minutes ago
Analysts Expect 4 S&P 500 Stocks To Outgrow Nvidia Next Year
Quartz
·
29 minutes ago
The Dow fell more than 700 points on Monday and the S&P 500 lost 1.9%
Benzinga
·
35 minutes ago
Shipping Stocks Rose 4.5% Last Week, Outperforming S&P 500; United Maritime Led Gains
Profile
NextCell Pharma AB is a Swedish biopharmaceutical company headquartered in Huddinge, in the Flemingsberg life-science cluster south of Stockholm. The company develops allogeneic mesenchymal stromal cell therapies, with its lead candidate aimed at preserving insulin production in newly diagnosed type 1 diabetes. Alongside its drug development programme, NextCell operates a private umbilical cord stem cell bank and a contract manufacturing and analytical services subsidiary for Advanced Therapy Medicinal Products. NextCell's shares trade on the Nasdaq First North Growth Market in Stockholm under the ticker NXTCL. Wikipedia
About NextCell Pharma AB
CEOMathias Svahn
Employees21
FoundedMar 19, 2014
Headquarters-
SectorHealth Care
IndustryBiotechnology
Websitenextcellpharma.com